Cambridge Investment Research Advisors, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 13,790 shares of AMPH stock, worth $358,677. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,790
Previous 12,096
14.0%
Holding current value
$358,677
Previous $449,000
10.91%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$155 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$63 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$57.5 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$41.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$35.3 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.27B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...